FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jasna Aleksandrovic

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Branislav Jeremic; Biljana Milicic; Aleksandar Dagovic; Jasna Aleksandrovic; Slobodan Milisavljevic
Interfraction interval in patients with stage III non-small-cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy: final results in 536 patients.
Branislav Jeremic; Biljana Milicic; Aleksandar Dagovic; Jasna Aleksandrovic; Slobodan Milisavljevic
Stage III non-small-cell lung cancer treated with high-dose hyperfractionated radiation therapy and concurrent low-dose daily chemotherapy with or without weekend chemotherapy: retrospective analysis of 301 patients.
Branislav Jeremic; Biljana Milicic; Danica Grujicic; Miroslav Samardzic; Vaso Antunovic; Aleksandar Dagovic; Jasna Aleksandrovic
Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jasna Aleksandrovic (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Branislav Jeremic; Biljana Milicic; Aleksandar Dagovic; Jasna Aleksandrovic; Slobodan Milisavljevic
Interfraction interval in patients with stage III non-small-cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy: final results in 536 patients.
American journal of clinical oncology 2004;27(6):616-25.
2004: Branislav Jeremic; Biljana Milicic; Aleksandar Dagovic; Jasna Aleksandrovic; Slobodan Milisavljevic
Stage III non-small-cell lung cancer treated with high-dose hyperfractionated radiation therapy and concurrent low-dose daily chemotherapy with or without weekend chemotherapy: retrospective analysis of 301 patients.
American journal of clinical oncology 2004;27(4):350-60.
2004: Branislav Jeremic; Biljana Milicic; Danica Grujicic; Miroslav Samardzic; Vaso Antunovic; Aleksandar Dagovic; Jasna Aleksandrovic
Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
International journal of radiation oncology, biology, physics 2004;59(2):509-14.
2004: Branislav Jeremic; Biljana Milicic; Danica Grujicic; Aleksandar Dagovic; Jasna Aleksandrovic; Nebojsa Nikolic
Clinical prognostic factors in patients with malignant glioma treated with combined modality approach.
American journal of clinical oncology 2004;27(2):195-204.
2003: Branislav Jeremic; Biljana Milicic; Danica Grujicic; Miroslav Samardzic; Vaso Antunovic; Aleksandar Dagovic; Jasna Aleksandrovic; Miroslav Stojanovic
Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma: a 10-year update of a phase II study.
International journal of radiation oncology, biology, physics 2003;57(2):465-71.
2003: Branislav Jeremic; Biljana Milicic; Danica Grujicic; Aleksandar Dagovic; Jasna Aleksandrovic
Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.
Journal of cancer research and clinical oncology 2003;129(8):477-84.
2003: Branislav Jeremic; Yuta Shibamoto; Biljana Milicic; Aleksandar Dagovic; Nebojsa Nikolic; Jasna Aleksandrovic; Ljubisa Acimovic; Slobodan Milisavljevic
Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone.
Lung cancer (Amsterdam, Netherlands) 2003;40(3):317-23.
2003: Branislav Jeremic; Biljana Milicic; Aleksandar Dagovic; Jasna Aleksandrovic; Nebojsa Nikolic
Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy.
Journal of cancer research and clinical oncology 2003;129(2):114-22.
2002: Branislav Jeremic; Yuta Shibamoto; Biljana Milicic; Aleksandar Dagovic; Jasna Aleksandrovic; Nebojsa Nikolic; Ivan Igrutinovic
No thoracic radiation myelitis after spinal cord dose > or = 50.4 Gy using 1.2. Gy b.i.d. fractionation in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2002;35(3):287-92.
2001: Branislav Jeremic; Yuta Shibamoto; Ljubisa Acimovic; Biljana Milicic; Slobodan Milisavljevic; Nebojsa Nikolic; Aleksandar Dagovic; Jasna Aleksandrovic; G Radosavljevic-Asic
Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial.
International journal of radiation oncology, biology, physics 2001;50(1):19-25.
2001: Branislav Jeremic; Yuta Shibamoto; Ljubisa Acimovic; Nebojsa Nikolic; Aleksandar Dagovic; Jasna Aleksandrovic; G Radosavljevic-Asic
Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1056-63.
2001: Branislav Jeremic; Yuta Shibamoto; Danica Grujicic; Miroslav Stojanovic; Biljana Milicic; Nebojsa Nikolic; Aleksandar Dagovic; Jasna Aleksandrovic
Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
Journal of neuro-oncology 2001;51(2):133-41.
2000: Branislav Jeremic; Yuta Shibamoto; Biljana Milicic; Nebojsa Nikolic; Aleksandar Dagovic; Jasna Aleksandrovic; Zeljko Vaskovic; Ljiljana Tadic
Elective ipsilateral neck irradiation of patients with locally advanced maxillary sinus carcinoma.
Cancer 2000;88(10):2246-51.
2000: Branislav Jeremic; Yuta Shibamoto; Biljana Milicic; Nebojsa Nikolic; Aleksandar Dagovic; Jasna Aleksandrovic; Zeljko Vaskovic; Ljiljana Tadic
Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(7):1458-64.
1999: Branislav Jeremic; Yuta Shibamoto; Biljana Milicic; Slobodan Milisavljevic; Nebojsa Nikolic; Aleksandar Dagovic; Jasna Aleksandrovic; G Radosavljevic-Asic
Prolonged oral versus high-dose intravenous etoposide in combination with carboplatin for stage IV non-small-cell lung cancer (NSCLC): a randomized trial.
Lung cancer (Amsterdam, Netherlands) 1999;25(3):207-14.
1999: Branislav Jeremic; Yuta Shibamoto; Danica Grujicic; Biljana Milicic; Miroslav Stojanovic; Nebojsa Nikolic; Aleksandar Dagovic; Jasna Aleksandrovic
Short-course radiotherapy in elderly and frail patients with glioblastoma multiforme. A phase II study.
Journal of neuro-oncology 1999;44(1):85-90.
1999: Branislav Jeremic; Yuta Shibamoto; Nebojsa Nikolic; Biljana Milicic; Slobodan Milisavljevic; Aleksandar Dagovic; Jasna Aleksandrovic; G Radosavljevic-Asic
Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2092-9.
1999: Branislav Jeremic; Yuta Shibamoto; D Gruijicic; Biljana Milicic; Miroslav Stojanovic; Nebojsa Nikolic; Aleksandar Dagovic; Jasna Aleksandrovic
Combined treatment modality for anaplastic oligodendroglioma: a phase II study.
Journal of neuro-oncology 1999;43(2):179-85.
1999: Branislav Jeremic; Yuta Shibamoto; Biljana Milicic; Slobodan Milisavljevic; Nebojsa Nikolic; Aleksandar Dagovic; Jasna Aleksandrovic; G Radosavljevic-Asic
A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 1999;44(2):343-8.
1999: Branislav Jeremic; Yuta Shibamoto; Danica Grujicic; Biljana Milicic; Miroslav Stojanovic; Nebojsa Nikolic; Aleksandar Dagovic; Jasna Aleksandrovic
Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;51(1):27-33.
1999: Branislav Jeremic; Yuta Shibamoto; Biljana Milicic; Slobodan Milisavljevic; Nebojsa Nikolic; Aleksandar Dagovic; Jasna Aleksandrovic; G Radosavljevic-Asic
External beam radiation therapy alone for loco-regional recurrence of non-small-cell lung cancer after complete resection.
Lung cancer (Amsterdam, Netherlands) 1999;23(2):135-42.
1998: Branislav Jeremic; Yuta Shibamoto; Ljubisa Acimovic; Biljana Milicic; Slobodan Milisavljevic; Nebojsa Nikolic; Jasna Aleksandrovic; Ivan Igrutinovic
A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain.
International journal of radiation oncology, biology, physics 1998;42(1):161-7.